Finch Therapeutics | 10-Q: Quarterly report
Finch Therapeutics Has Been Granted European Patent Number EP3664823 Titled "Composition For Use In Preventing Or Treating An Enterococcal Blood Stream Infection".
Finch Therapeutics Has Been Granted European Patent Number EP3664823 Titled "Composition For Use In Preventing Or Treating An Enterococcal Blood Stream Infection".
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Teledyne Technologies Incorporated (NYSE:TDY) fell sharply during Wednesday's session after the company reported worse-than-expected first-quarter financial results and cut FY24 adjusted EPS
CSSE, RVYL and RCAT Among Mid-day Movers
Immutep, Capricor Therapeutics, Cyclacel Pharmaceuticals Among Healthcare Movers
ING, PALI and FNCH Among Pre-market Losers
ENPH, SEDG and MEDP Are Among After Hour Movers
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of The Travelers Companies, Inc. (NYSE:TRV) fell sharply during Wednesday's session following first-quarter earnings. Travelers reported a mixed first quarter, with earnings lagging analyst' e
Lexaria Bioscience, Biosig Technologies, BIMI Holdings Among Healthcare Movers
12 Health Care Stocks Moving In Friday's After-Market Session
GainersQilian Intl Hldg Gr (NASDAQ:QLI) stock moved upwards by 50.4% to $1.14 during Friday's after-market session. The company's market cap stands at $40.7 million. Allarity Therapeutics (NASDAQ:ALLR
Finch Therapeutics(FNCH.US) Director Sells US$21,245.94 in Common Stock
$Finch Therapeutics(FNCH.US)$ Director SMISEK JEFFERY A sold 8,242 shares of Common Stock on Mar 28, 2024 at an average price of $2.58 for a total value of $21,245.94.Source: Announcement What is stat
Finch Therapeutics Gr Q4 EPS $(1.89) Up From $(16.80) YoY
Finch Therapeutics Gr (NASDAQ:FNCH) reported quarterly losses of $(1.89) per share. This is a 88.75 percent increase over losses of $(16.80) per share from the same period last year.
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersRegulus Therapeutics (NASDAQ:RGLS) stock moved upwards by 84.8% to $2.55 during Tuesday's pre-market session. The company's market cap stands at $51.5 million. Assure Hldgs (NASDAQ:IONM) stock
Finch Therapeutics Faces Nasdaq Delisting and Patent Litigation
AMKR, ALKS and CLFD Are Among After Hour Movers
Redhill Biopharma, Ampio Pharmaceuticals Among Healthcare Movers
Finch Therapeutics(FNCH.US) Director Sells US$5,350.8 in Common Stocks
$Finch Therapeutics(FNCH.US)$ Director SMISEK JEFFERY A sold 1,470 shares of Common Stocks on Nov 22, 2023 at an average price of $3.64 for a total value of $5,350.8.Source: Announcement What is state
Finch Therapeutics Gr Q3 EPS $(1.51) Up From $(25.38) YoY
Finch Therapeutics Gr (NASDAQ:FNCH) reported quarterly losses of $(1.51) per share. This is a 94.05 percent increase over losses of $(25.38) per share from the same period last year.
Stocks That Hit 52-Week Lows On Friday
Friday's session saw 112 companies set new 52-week lows. Intriguing Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Hershey (NYSE:HSY).The smallest c
Analysts Are Bullish on These Healthcare Stocks: Nuvation Bio (NUVB), Finch Therapeutics Group (FNCH)
No Data